These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 8376846

  • 1. Macrophage-directed delivery of doxorubicin conjugated to neoglycoprotein using leishmaniasis as the model disease.
    Sett R, Sarkar K, Das PK.
    J Infect Dis; 1993 Oct; 168(4):994-9. PubMed ID: 8376846
    [Abstract] [Full Text] [Related]

  • 2. Neoglycoproteins as carriers for receptor-mediated drug targeting in the treatment of experimental visceral leishmaniasis.
    Chakraborty P, Bhaduri AN, Das PK.
    J Protozool; 1990 Oct; 37(5):358-64. PubMed ID: 2213650
    [Abstract] [Full Text] [Related]

  • 3. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
    Sarkar K, Das PK.
    J Immunol; 1997 Jun 01; 158(11):5357-65. PubMed ID: 9164956
    [Abstract] [Full Text] [Related]

  • 4. Neoglycoprotein conjugated liposomes as macrophage specific drug carrier in the therapy of leishmaniasis.
    Kole L, Sakar K, Mahato SB, Das PK.
    Biochem Biophys Res Commun; 1994 Apr 15; 200(1):351-8. PubMed ID: 8166705
    [Abstract] [Full Text] [Related]

  • 5. Sugar receptor mediated drug delivery to macrophages in the therapy of experimental visceral leishmaniasis.
    Chakraborty P, Bhaduri AN, Das PK.
    Biochem Biophys Res Commun; 1990 Jan 15; 166(1):404-10. PubMed ID: 2302213
    [Abstract] [Full Text] [Related]

  • 6. Synergistic effect of interferon-gamma and mannosylated liposome-incorporated doxorubicin in the therapy of experimental visceral leishmaniasis.
    Kole L, Das L, Das PK.
    J Infect Dis; 1999 Sep 15; 180(3):811-20. PubMed ID: 10438370
    [Abstract] [Full Text] [Related]

  • 7. Potential of doxorubicin as an antileishmanial agent.
    Sett R, Basu N, Ghosh AK, Das PK.
    J Parasitol; 1992 Apr 15; 78(2):350-4. PubMed ID: 1556650
    [Abstract] [Full Text] [Related]

  • 8. Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis.
    Kansal S, Tandon R, Dwivedi P, Misra P, Verma PR, Dube A, Mishra PR.
    J Antimicrob Chemother; 2012 Nov 15; 67(11):2650-60. PubMed ID: 22872448
    [Abstract] [Full Text] [Related]

  • 9. Targeting of parasite-specific immunoliposome-encapsulated doxorubicin in the treatment of experimental visceral leishmaniasis.
    Mukherjee S, Das L, Kole L, Karmakar S, Datta N, Das PK.
    J Infect Dis; 2004 Mar 15; 189(6):1024-34. PubMed ID: 14999606
    [Abstract] [Full Text] [Related]

  • 10. Targeting of piperine intercalated in mannose-coated liposomes in experimental leishmaniasis.
    Raay B, Medda S, Mukhopadhyay S, Basu MK.
    Indian J Biochem Biophys; 1999 Aug 15; 36(4):248-51. PubMed ID: 10650726
    [Abstract] [Full Text] [Related]

  • 11. Effect of sodium stibogluconate and pentamidine on in vitro multiplication of Leishmania donovani in peritoneal macrophages from infected and drug-treated BALB/c mice.
    Sodhi S, Kaur S, Mahajan RC, Ganguly NK, Malla N.
    Immunol Cell Biol; 1992 Feb 15; 70 ( Pt 1)():25-31. PubMed ID: 1322361
    [Abstract] [Full Text] [Related]

  • 12. Overexpressed Macrophage Mannose Receptor Targeted Nanocapsules- Mediated Cargo Delivery Approach for Eradication of Resident Parasite: In Vitro and In Vivo Studies.
    Asthana S, Gupta PK, Jaiswal AK, Dube A, Chourasia MK.
    Pharm Res; 2015 Aug 15; 32(8):2663-77. PubMed ID: 25715698
    [Abstract] [Full Text] [Related]

  • 13. Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani.
    Chaubey P, Mishra B, Mudavath SL, Patel RR, Chaurasia S, Sundar S, Suvarna V, Monteiro M.
    Int J Biol Macromol; 2018 May 15; 111():109-120. PubMed ID: 29307805
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of mannose receptors on macrophages after infection with Leishmania donovani.
    Basu N, Sett R, Das PK.
    Biochem J; 1991 Jul 15; 277 ( Pt 2)(Pt 2):451-6. PubMed ID: 1859373
    [Abstract] [Full Text] [Related]

  • 15. Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani.
    Gaspar R, Opperdoes FR, Préat V, Roland M.
    Ann Trop Med Parasitol; 1992 Feb 15; 86(1):41-9. PubMed ID: 1616394
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and biodistribution of methotrexate conjugated to mannosyl human serum albumin.
    Sett R, Sarkar HS, Das PK.
    J Antimicrob Chemother; 1993 Jan 15; 31(1):151-9. PubMed ID: 8444658
    [Abstract] [Full Text] [Related]

  • 17. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N, Mukherjee S, Das L, Das PK.
    Eur J Immunol; 2003 Jun 15; 33(6):1508-18. PubMed ID: 12778468
    [Abstract] [Full Text] [Related]

  • 18. An experimental model system for leishmaniasis. Effects of porphyrin-compounds and menadione on Leishmania parasites engulfed by cultured macrophages.
    Abok K, Cadenas E, Brunk U.
    APMIS; 1988 Jun 15; 96(6):543-51. PubMed ID: 3395481
    [Abstract] [Full Text] [Related]

  • 19. Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis.
    Mitra M, Mandal AK, Chatterjee TK, Das N.
    J Drug Target; 2005 Jun 15; 13(5):285-93. PubMed ID: 16199372
    [Abstract] [Full Text] [Related]

  • 20. Development of doxorubicin loaded novel core shell structured nanocapsules for the intervention of visceral leishmaniasis.
    Kansal S, Tandon R, Verma PR, Dube A, Mishra PR.
    J Microencapsul; 2013 Jun 15; 30(5):441-50. PubMed ID: 23534494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.